StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report released on Monday morning. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE opened at $0.38 on Monday. The company has a market capitalization of $433,200.00, a P/E ratio of -0.03 and a beta of 1.96. Ampio Pharmaceuticals has a one year low of $0.14 and a one year high of $8.30. The business’s 50 day simple moving average is $1.17 and its 200-day simple moving average is $1.85.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last announced its earnings results on Wednesday, March 27th. The company reported ($2.48) EPS for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- The 3 Hottest Insiders Buys This Month
- P/E Ratio Calculation: How to Assess Stocks
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- How to Most Effectively Use the MarketBeat Earnings Screener
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
